Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | FEBS Open Bio |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1870568931061661696 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | FEBS Open Bio |
| description | |
| discipline_display | Biochemistry |
| discipline_facet | Biochemistry |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:102545 |
| institution | FRELIP |
| journal_source_facet | FEBS Open Bio |
| last_indexed | 2026-07-13T03:32:26.592Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease Biochemistry General Biochemistry |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Biochemistry General Biochemistry |
| subject_facet | Biochemistry General Biochemistry |
| title | Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease |
| title_alt | El tratamiento con KCL‐286, un agonista del receptor de ácido retinoico β (RARβ) de primera clase, mejora el daño neuronal del ADN y la inflamación en un modelo de ratón con enfermedad de Alzheimer Le traitement par KCL‐286, un agoniste de première classe du récepteur de l'acide rétinoïque β (RARβ), atténue les dommages à l'ADN neuronal et l'inflammation dans un modèle murin de la maladie d'Alzheimer Tratamento com KCL‐286, um agonista do receptor de ácido retinoico β (RARβ) inovador, melhora o dano neuronal ao DNA e a inflamação em um modelo de camundongo da doença de Alzheimer |
| title_auth | Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease |
| title_es_txt | El tratamiento con KCL‐286, un agonista del receptor de ácido retinoico β (RARβ) de primera clase, mejora el daño neuronal del ADN y la inflamación en un modelo de ratón con enfermedad de Alzheimer |
| title_fr_txt | Le traitement par KCL‐286, un agoniste de première classe du récepteur de l'acide rétinoïque β (RARβ), atténue les dommages à l'ADN neuronal et l'inflammation dans un modèle murin de la maladie d'Alzheimer |
| title_full | Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease |
| title_fullStr | Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease |
| title_full_unstemmed | Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease |
| title_pt_txt | Tratamento com KCL‐286, um agonista do receptor de ácido retinoico β (RARβ) inovador, melhora o dano neuronal ao DNA e a inflamação em um modelo de camundongo da doença de Alzheimer |
| title_short | Treatment with KCL‐286, a first‐in‐class retinoic acid receptor‐β (RARβ) agonist, ameliorates neuronal DNA damage and inflammation in a mouse model of Alzheimer's disease |
| title_sort | treatment with kcl‐286, a first‐in‐class retinoic acid receptor‐β (rarβ) agonist, ameliorates neuronal dna damage and inflammation in a mouse model of alzheimer's disease |
| topic | Biochemistry General Biochemistry |
| url | https://febs.onlinelibrary.wiley.com/doi/10.1002/2211-5463.70284?af=R |